Literature DB >> 7378342

Tryptophan and the control of triglyceride and carbohydrate metabolism in the rat.

R Fears, E A Murrell.   

Abstract

1. Hepatic fatty acid synthesis, measured in vivo using 3H2O, was increased by a single dose of L-tryptophan (50 mg/kg body-weight) to both fed and fasted rats and by a supplement of tryptophan to the diet (2.5 g/kg diet for 7 d) when the rats were killed midway through the feeding period. 2. Additional dietary tryptophan was hypotriglyceridaemic in normal rats but exacerbated the hypertriglyceridaemia in rats when lipoprotein clearance was impaired 24 h after an injection of Triton WR 1339 (Chromatography Services Co., Birkenhead, Cheshire). 3. The effects of tryptophan on hepatic fatty acid synthesis and the concentration of serum triglyceride were not directly related to the action of the amino acid on gluconeogenesis. A lack of correlation between inhibition of gluconeogenesis and enhancement of lipogenesis was confirmed using mercaptopicolinic acid, a specific inhibitor of phosphoenolpyruvate carboxykinase (EC 4.1.1.32). 4. DL-Tryptophan itself did not provide a significant contribution of substrate to the total rate of lipogenesis. Other possible explanations for the activity of tryptophan noted in the present experiments are discussed. 5. In conclusion, moderate intakes of tryptophan affect fatty acid and triglyceride metabolism under physiological conditions and it is proposed that the amino acid may be involved in the control of lipid metabolism in a variety of metabolic states.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378342     DOI: 10.1079/bjn19800097

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

Review 1.  The contribution of the cholesterol biosynthetic pathway to intermediary metabolism and cell function.

Authors:  R Fears
Journal:  Biochem J       Date:  1981-10-01       Impact factor: 3.857

2.  The Kynurenine Pathway in Obese Middle-Aged Women with Normoglycemia and Type 2 Diabetes.

Authors:  Justyna Kubacka; Magdalena Staniszewska; Ilona Sadok; Grazyna Sypniewska; Anna Stefanska
Journal:  Metabolites       Date:  2022-05-29

Review 3.  The Kynurenine Pathway and Polycystic Ovary Syndrome: Inflammation as a Common Denominator.

Authors:  Filip Jovanovic; Aboorva Sudhakar; Nebojsa Nick Knezevic
Journal:  Int J Tryptophan Res       Date:  2022-05-21

4.  Distribution of L-tryptophan in normal and glucose - loaded mice.

Authors:  E L Sainio; S Närvänen; P Sainio; P Tuohimaa
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

5.  L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin.

Authors:  Yosuke Osawa; Hiromitsu Kanamori; Ekihiro Seki; Masato Hoshi; Hirofumi Ohtaki; Yoichi Yasuda; Hiroyasu Ito; Atsushi Suetsugu; Masahito Nagaki; Hisataka Moriwaki; Kuniaki Saito; Mitsuru Seishima
Journal:  J Biol Chem       Date:  2011-08-12       Impact factor: 5.157

6.  Dietary Tryptophan and the Risk of Metabolic Syndrome: Total Effect and Mediation Effect of Sleep Duration.

Authors:  Weiqi Wang; Lin Liu; Zhen Tian; Tianshu Han; Changhao Sun; Ying Li
Journal:  Nat Sci Sleep       Date:  2021-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.